Abstract
Objective: To investigate the clinical application value of the molecular imaging SPECT/CT for bone metastases of breast cancer. Methods: Both MSCT and SPECT/CT imaging data of 68 suspicious bone metastases lesions of breast cancer were retrospectively analyzed and compared, and the statistics checkout was carried out. Resluts: Among the 55 bone metastases lesions of breast cancer, sensitivity, specificity and accuracy of bone metastases diagnosed by MSCT were 78.2％(43/55), 92.3%(12/13) and 80.9%(55/68); and sensitivity, specificity and accuracy of bone metastases diagnosed by SPECT/CT were 96.4％(53/55), 76.9%(10/13) and 92.6%(63/68). For the difference of the sensitivity and accuracy, there was statistically significance between MSCT and SPECT methods(P＜0.05), and the specificity of both methods was no difference. Conclusions: Comparing with MSCT, the SPECT/CT fusion imaging can improve the sensitivity and accuracy of the bone metastases diagnosis of breast cancer, and having better clinical application value.
Key words
Breast neoplasms /
Neoplasm metastasis /
Tomography /
emission-computed /
single-photon
Cite this article
Download Citations
DONG Ke;FU Jian-fei;LOU Jing-jing;LIU Jiang.
The clinical application value of molecular imaging SPECT/CT for bone metastases from breast cancer[J]. Journal of China Clinic Medical Imaging. 2015, 26(7): 465-468
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
